Gallstones and the gallbladder
Wegovy’s and Ozempic’s leaflets list gallstones as common, up to 1 in 10, and Mounjaro’s says they were common when used for weight management. The NHS tirzepatide page lists gallstones or a swollen gallbladder as serious. Zepbound’s label says gallbladder events in its trials were associated with weight reduction.
How common it is
Each leaflet’s own words for how common gallstones are, quoted as written. Zepbound’s figure is the share of people in its two weight trials.
| Medicine | How common |
|---|---|
| Mounjaro | Increased gallstones were common in the cardiovascular disease study and when used for weight management but uncommon when used in adults for type 2 diabetes.Mounjaro KwikPen patient leaflet |
| Zepbound | 1.1%, against 1% on placebo |
| Wegovy | Common: may affect up to 1 in 10 peopleWegovy FlexTouch patient leaflet |
| Ozempic | Common (may affect up to 1 in 10 people)Ozempic patient leaflet |
What else they say
Linked to weight loss
Zepbound’s label says acute gallbladder events in its two weight trials were associated with weight reduction.
A swollen gallbladder
In those trials, cholecystitis (swelling of the gallbladder) was reported by 0.7% on Zepbound, against 0.2% on placebo.
The NHS on tirzepatide
The NHS tirzepatide page lists gallstones or swelling of the gallbladder, which can cause severe tummy pain, as serious.
Gallbladder signs
Zepbound’s label lists signs to tell your provider about: upper stomach pain, fever, yellow skin or eyes, clay-colored stools.
Questions
Can Mounjaro cause gallstones?
Mounjaro’s leaflet says gallstones were common when it was used for weight management, up to 1 in 10 people, and uncommon in adults treated for type 2 diabetes.
Does Wegovy cause gallstones?
Wegovy’s and Ozempic’s leaflets both list gallstones as common, up to 1 in 10 people. The NHS semaglutide page doesn’t list them.
What does the NHS say?
The NHS tirzepatide page lists gallstones or swelling of the gallbladder among serious side effects, and says call 111 if you think you’re having one.
Progress by dose
Your weight, drawn across each dose.
Record each new strength and the day you started it. Progress shades every dose as its own band and runs your weigh-ins across them, so you can see what each dose did.

Sources
- Mounjaro KwikPen patient leaflet
- Zepbound prescribing information
- Wegovy FlexTouch patient leaflet
- Ozempic patient leaflet
- NHS: Tirzepatide
- NHS: Semaglutide
General information, not medical advice. Follow your prescriber’s guidance.
Getting real advice
We’re not doctors. This page sums up what the NHS and the official medicine information say, and can’t tell you what’s right for your body: your prescriber’s instructions and the leaflet in your box come first. More in our terms.
- Quoted from official sources, each one linked
- Sources checked 12 October 2026
- No dosing advice; your prescriber comes first
- A pharmacist, your doctor or NHS 111If you’re not sure how to use your medicine, or a side effect bothers you or won’t go away. NHS 111 if you think you might be having serious side effects, or you’ve used too much.NHS: SemaglutideNHS: TirzepatideNHS 111 online
- Report a side effectAnyone can, not only doctors.Yellow Card (UK)MedWatch (US)